SEARCH

SEARCH BY CITATION

References

  • 1
    UNAIDS. 2006 Report on the Global AIDS Epidemic . http://www.UNAIDS.org 2006.
  • 2
    Joint United Nations Programme on HIV/AIDS/World Health Organization (UNAIDS/WHO). “3 by 5” Progress Report, December 2004 . http://www.who.int/3by5/en/ProgressReportfinal.pdf 2004.
  • 3
    World Bank. Confronting AIDS: Public Priorities in a Global Epidemic, Revised Edition. New York, NY: Oxford University Press, 1999.
  • 4
    Cook JA, Grey D, Burke J et al. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health 2004; 94: 11331140.
  • 5
    Ickovics JR, Hamburger ME, Vlahov D et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. J Am Med Assoc 2001; 285: 14661474.
  • 6
    Moore J, Schuman P, Schoenbaum E, Boland B, Solomon L, Smith D. Severe adverse life events and depressive symptoms among women with, or at risk for, HIV infection in four cities in the United States of America. AIDS 1999; 13: 24592468.
  • 7
    Tostes MA, Chalub M, Botega NJ. The quality of life of HIV-infected women is associated with psychiatric morbidity. AIDS Care 2004; 16: 177186.
  • 8
    Watanabe M, Nishimura K, Inoue T, Kimura S, Oka S. QoL Research Group of the AIDS Clinical Centre and Eight Regional AIDS Treatment Hospitals in Japan. A discriminative study of health-related quality of life assessment in HIV-1-infected persons living in Japan using the Multidimensional Quality of Life Questionnaire for persons with HIV/AIDS. Int J STD AIDS 2004; 15: 107115.
  • 9
    Kemmler G, Schmied B, Shetty-Lee A et al. Quality of life of HIV-infected patients: psychometric properties and validation of the German version of the MQOL-HIV. Qual Life Res 2003; 12: 10371050.
  • 10
    Riley ED, Bangsberg DR, Perry S, Clark RA, Moss AR, Wu AW. Reliability and validity of the SF-36 in HIV-infected homeless and marginally housed individuals. Qual Life Res 2003; 12: 10511058.
  • 11
    Tate D, Paul RH, Flanigan TP et al. The impact of apathy and depression on quality of life in patients infected with HIV. AIDS Patient Care STDs 2003; 17: 115120.
  • 12
    Molassiotis A, Callaghan P, Twinn SF, Lam SW. Correlates of quality of life in symptomatic HIV patients living in Hong Kong. AIDS Care 2001; 13: 319334.
  • 13
    Sherbourne CD, Hays RD, Fleishman JA et al. Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry 2000; 157: 248254.
  • 14
    Blaney NT, Fernandez MI, Ethier KA, Wilson TE, Walter E, Koenig LJ. Psychosocial and behavioral correlates of depression among HIV-infected pregnant women. AIDS Patient Care STDs 2004; 18: 405415.
  • 15
    Rochat TJ, Richter LM, Doll HA, Buthelezi NP, Tomkins A, Stein A. Depression among pregnant rural South African women undergoing HIV testing. J Am Med Assoc 2006; 295: 13761378.
  • 16
    Ethier KA, Ickovics JR, Fernandez MI, Wilson TE, Royce RA, Koenig LJ. The Perinatal Guidelines Evaluation Project HIV and Pregnancy Study: overview and cohort description. Public Health Rep 2002; 117: 137147.
  • 17
    Kwalombota M. The effect of pregnancy in HIV-infected women. AIDS Care 2002; 14: 431433.
  • 18
    Tolmunen T, Voutilainen S, Hintikka J et al. Dietary folate and depressive symptoms are associated in middle-aged Finnish men. J Nutr 2003; 133: 32333236.
  • 19
    Tiemeier H, Van Tuijl HR, Hofman A, Meijer J, Kiliaan AJ, Breteler MM. Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study. Am J Psychiatry 2002; 159: 20992101.
  • 20
    Penninx BW, Guralnik JM, Ferrucci L, Fried LP, Allen RH, Stabler SP. Vitamin B(12) deficiency and depression in physically disabled older women. epidemiologic evidence from the Women's Health and Aging Study. Am J Psychiatry 2000; 157: 715721.
  • 21
    Bell IR, Edman JS, Morrow FD et al. Brief communication. Vitamin B1, B2, and B6 augmentation of tricyclic antidepressant treatment in geriatric depression with cognitive dysfunction. J Am Coll Nutr 1992; 11: 159163.
  • 22
    Baldewicz TT, Goodkin K, Blaney NT et al. Cobalamin level is related to self-reported and clinically rated mood and to syndromal depression in bereaved HIV-1(+) and HIV-1(−) homosexual men. J Psychosom Res 2000; 48: 177185.
  • 23
    Fawzi WW, Msamanga GI, Spiegelman D et al. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med 2004; 351: 2332.
  • 24
    World Health Organization (WHO). Interim proposal for a WHO staging system for HIV infection and disease. Wkly Epidemiol Rec 1990; 65: 221244.
  • 25
    Fawzi WW, Msamanga GI, Spiegelman D, Urassa EJ, Hunter DJ. Rationale and design of the Tanzania Vitamin and HIV Infection Trial. Control Clin Trials 1999; 20: 7590.
  • 26
    Fawzi WW, Msamanga GI, Wei R et al. Effect of providing vitamin supplements to human immunodeficiency virus-infected, lactating mothers on the child's morbidity and CD4+cell counts. Clin Infect Dis 2003; 36: 10531062.
  • 27
    Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist (HSCL). A measure of primary symptom dimensions. Mod Probl Pharmacopsychiatry 1974; 7: 79110.
  • 28
    Kaaya SF, Smith Fawzi MC, Mbwambo JK, Lee B, Msamanga GI, Fawzi W. Validity of the Hopkins Symptom Checklist-25 amongst HIV-positive pregnant women in Tanzania. Acta Psychiatr Scand 2002; 106: 919.
  • 29
    Ware J, Snow K, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: The Health Institute, 1993.
  • 30
    Wyss K, Wagner AK, Whiting D et al. Validation of the Kiswahili version of the SF-36 Health Survey in a representative sample of an urban population in Tanzania. Qual Life Res 1999; 8: 111120.
  • 31
    Diggle PJ, Liang KY, Zeger SI. Analysis of Longitudinal Data. London, UK: Oxford University Press, 1994.
  • 32
    Bennetts A, Shaffer N, Manopaiboon C et al. Determinants of depression and HIV-related worry among HIV-positive women who have recently given birth, Bangkok, Thailand. Social Sci Med 1999; 49: 737749.
  • 33
    Bastardo YM, Kimberlin CL. Relationship between quality of life, social support and disease-related factors in HIV-infected persons in Venezuela. AIDS Care 2000; 12: 673684.
  • 34
    Fava M, Borus JS, Alpert JE, Nierenberg AA, Rosenbaum JF, Bottiglieri T. Folate, vitamin B12, and homocysteine in major depressive disorder. Am J Psychiatry 1997; 154: 426428.
  • 35
    Bottiglieri T, Hyland K, Laundy M et al. Folate deficiency, biopterin and monoamine metabolism in depression. Psychol Med 1992; 22: 871876.
  • 36
    Abou-Saleh MT, Coppen A. Serum and red blood cell folate in depression. Acta Psychiatr Scand 1989; 80: 7882.
  • 37
    Morris MS, Fava M, Jacques PF, Selhub J, Rosenberg IH. Depression and folate status in the US population. Psychother Psychosom 2003; 72: 8087.
  • 38
    Bottiglieri T. Folate, vitamin B12, and neuropsychiatric disorders. Nutr Rev 1996; 54: 382390.
  • 39
    Widner B, Fuchs D, Leblhuber F, Sperner-Unterweger B. Does disturbed homocysteine and folate metabolism in depression result from enhanced oxidative stress? J Neurol Neurosurg Psychiatry 2001; 70: 419.
  • 40
    Bottiglieri T, Laundy M, Crellin R, Toone BK, Carney MW, Reynolds EH. Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry 2000; 69: 228232.
  • 41
    Maes M, De Vos N, Pioli R et al. Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness. J Affect Disord 2000; 58: 241246.
  • 42
    Peet M, Murphy B, Shay J, Horrobin D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 1998; 43: 315319.
  • 43
    Anonymous. Vanadium vitamin C and depression. Nutr Rev 1982; 40: 293295.
  • 44
    Cocchi P, Silenzi M, Calabri G, Salvi G. Antidepressant effect of vitamin C. Pediatrics 1980; 65: 862863.
  • 45
    Shibata H, Kumagai S, Watanabe S, Suzuki T. Relationship of serum cholesterols and vitamin E to depressive status in the elderly. J Epidemiol 1999; 9: 261267.
  • 46
    Tiemeier H, Hofman A, Kiliaan AJ, Meijer J, Breteler MM. Vitamin E and depressive symptoms are not related: The Rotterdam Study. J Affect Disord 2002; 72: 7983.
  • 47
    Hvas AM, Juul S, Nexo E, Ellegaard J. Vitamin B-12 treatment has limited effect on health-related quality of life among individuals with elevated plasma methylmalonic acid: a randomized placebo-controlled study. J Intern Med 2003; 253: 146152.
  • 48
    Carlsson CM, Papcke-Benson K, Carnes M, McBride PE, Stein JH. Health-related quality of life and long-term therapy with pravastatin and tocopherol (vitamin E) in older adults. Drugs Aging 2002; 19: 793805.
  • 49
    Keith ME, Jeejeebhoy KN, Langer A et al. A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure. Am J Clin Nutr 2001; 73: 219224.
  • 50
    Fawzi WW, Msamanga GI, Spiegelman D et al. Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet 1998; 351: 14771482.
  • 51
    Reichlin S. Neuroendocrine–immune interactions. N Engl J Med 1993; 329: 12461253.
  • 52
    Stein M, Miller AH, Trestman RL. Depression, the immune system, and health and illness. Findings in search of meaning. Arch Gen Psychiatry 1991; 48: 171177.
  • 53
    Evans DL, Leserman J, Pedersen CA et al. Immune correlates of stress and depression. Psychopharmacol Bull 1989; 25: 319324.
  • 54
    Leserman J, Petitto JM, Perkins DO, Folds JD, Golden RN, Evans DL. Severe stress, depressive symptoms, and changes in lymphocyte subsets in human immunodeficiency virus-infected men. A 2-year follow-up study. Arch Gen Psychiatry 1997; 54: 279285.
  • 55
    Burack JH, Barrett DC, Stall RD, Chesney MA, Ekstrand ML, Coates TJ. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. J Am Med Assoc 1993; 270: 25682573.
  • 56
    Lyketsos CG, Hoover DR, Guccione M et al. Depressive symptoms as predictors of medical outcomes in HIV infection. Multicenter AIDS Cohort Study. J Am Med Assoc 1993; 270: 25632567.
  • 57
    Perry S, Fishman B, Jacobsberg L, Frances A. Relationships over 1 year between lymphocyte subsets and psychosocial variables among adults with infection by human immunodeficiency virus. Arch Gen Psychiatry 1992; 49: 396401.
  • 58
    Rabkin JG, Williams JB, Remien RH, Goetz R, Kertzner R, Gorman JM. Depression, distress, lymphocyte subsets, and human immunodeficiency virus symptoms on two occasions in HIV-positive homosexual men. Arch Gen Psychiatry 1991; 48: 111119.
  • 59
    Cook JA, Cohen MH, Burke J et al. Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women. J Acquir Immune Defic Syndr 2002; 30: 401409.